HHY News 10.14 Helios High Yield Fund (HHY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Helios High Yield Fund (HHY) 10.14 $HHY

Brookfield Funds' Monthly Dividend Declaration
Marketwire - Fri Apr 04, 3:17PM CDT
Brookfield Global Listed Infrastructure Income Fund Inc. (NYSE: INF), Brookfield High Income Fund Inc. (NYSE: HHY), Brookfield Mortgage Opportunity Income Fund Inc. (NYSE: BOI) and Brookfield Total Return Fund Inc. (NYSE: HTR) (each, a "Fund," and collectively, the "Funds" today announced that their Boards of Directors declared their monthly dividends.

Brookfield Investment Management Inc. Announces Board Approval of the Reorganizations
Marketwire - Thu Feb 27, 5:47PM CST
Brookfield Investment Management Inc. (the "Adviser" announced today that the Board of Directors/Trustees of each of Helios Advantage Income Fund, Inc. (NYSE: HAV), Helios High Income Fund, Inc. (NYSE: HIH), Helios Multi-Sector High Income Fund, Inc. (NYSE: HMH), Helios Strategic Income Fund, Inc. (NYSE: HSA) and Helios High Yield Fund (NYSE: HHY) (each a "Fund" and together, the "Funds" have approved the reorganization of each of HAV, HIH, HMH and HSA into HHY (the "Reorganizations". In order to effect the Reorganizations and subject to shareholder approval of all the Funds' shareholders, HAV, HIH, HMH and HSA common shareholders will be issued HHY common stock and HHY would acquire substantially all of the assets and liabilities of HAV, HIH, HMH and HSA.

Helios Funds' Monthly Dividend Declaration
Marketwire - Fri Feb 07, 4:31PM CST
Helios Advantage Income Fund, Inc. (NYSE: HAV), Helios High Income Fund, Inc. (NYSE: HIH), Helios High Yield Fund (NYSE: HHY), Helios Multi-Sector High Income Fund, Inc. (NYSE: HMH) and Helios Strategic Income Fund, Inc. (NYSE: HSA) (each, a "Fund," and collectively, the "Funds" today announced that their Boards of Directors/Trustees declared their monthly dividends.

Helios High Yield Fund Announces Results of Special Shareholder Meeting
Marketwire - Fri Jan 31, 3:21PM CST
Helios High Yield Fund (NYSE: HHY) (the "Fund" today announced that, at its special shareholder meeting, shareholders of the Fund approved the redomestication of the Fund into a Maryland corporation and amendments to the Fund's governing documents. Additionally, shareholders approved a new investment advisory agreement between the Fund and Brookfield Investment Management. The redomestication is expected to be consummated on or about February 28, 2014.

Helios High Yield Fund Special Dividend Declaration
Marketwire - Wed Dec 11, 4:05PM CST
Helios High Yield Fund (NYSE: HHY) (the "Fund" today announced that its Board of Trustees declared a special dividend of $0.02 per share, payable on December 27, 2013 to shareholders of record on December 26, 2013. The ex-dividend date is December 23, 2013. In order to be compliant with federal tax requirements, the special dividend will be paid from the Fund's undistributed net investment income.

Helios High Yield Fund Monthly Dividend Declaration
Marketwire - Fri Dec 06, 4:11PM CST
Helios High Yield Fund (NYSE: HHY) (the "Fund" today announced that its Board of Trustees declared a monthly dividend of $0.075 per share, payable on December 27, 2013 to shareholders of record on December 19, 2013. The ex-dividend date is December 17, 2013. Based on the NYSE closing price of $9.76 on December 5, 2013, the Fund's annualized dividend yield is 9.22%.

Ex-Dividend Alert: 5 Stocks Going Ex-Dividend Tomorrow: HHY, GLAD, BOI, PL, PSX
at The Street - Mon Nov 11, 9:00AM CST
HHY GLAD BOI PL PSX are going ex-dividend tomorrow, Nov. 12, 2013
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading